Catalyst Wire Dossier Catalyst Wire Dossier

BI 705564

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 705564, covering 2022-07-06 to 2022-07-11. Get the full timeline:

Most recent: Clinical Trial Update: This Study in Healthy Men Tests How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 705564 Affects the Way the Body Breaks Down Midazolam [Phase 1]

See pricing